2026 payer coverage update — GLP-1 formulary changes by insurer

sean_dublin said:

InsuranceTom said: ...regarding the discontinuation data for cost and coverage...

Same pattern here, and in the same order. Posting only so the count is not one.

VendorMark said:

Insurance update relevant to cost and coverage: I just got my prior auth approved through Blue Cross after 1 attempts.

Bookmarking. The distinction being drawn above is the one nobody else makes. I will report back once I have actually tried it.

Adding the clinical framing, because it changes how the question reads.

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

1. Prior authorization appeal with peer-to-peer review
2. Manufacturer copay card (for commercial insurance)
3. Patient assistance programs (Novo Nordisk, Eli Lilly)
4. Compounded medication from a 503B pharmacy ($109/month)
5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

Dr.PeteFamMed said:

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives: Prior authorization appeal…

This matches mine closely enough to be worth saying so out loud. I had assumed I was the exception until I read this.

Moderator note: a couple of off-topic posts removed. Report rather than reply if it drifts again.